The development and evaluation of a labor risk model consisting of a combination of antepartum risk factors and intrapartum fetal heart rate (FHR) characteristics that can reliably identify those infants at risk for adverse neonatal outcome in labor. STUDY DESIGN: A nested case-control study of term singleton deliveries at the nine hospitals between March 2007 and December 2009. Eligibility criteria included: gestational age X37.0 weeks; singleton pregnancy; documented continuous FHR monitoring for X2 h before delivery; assessment of FHR tracing at least every 20 min; and, available maternal and neonatal outcomes. Adverse neonatal outcome was defined as nonanomalous infants admitted to the newborn intensive care unit with either a 5 minute Apgar score o7 or an umbilical artery pHo7.1. Initial risk score was determined using data available at 1 h after admission. Patients with an initial risk score between 7 and 15 were considered high risk. Intrapartum risk scores were then created for these patients using FHR tracing data and labor characteristics. RESULT: A total of 51 244 patients were identified meeting study criteria. Of the antepartum variables evaluated (n ¼ 31), 10 were associated with an adverse outcome. The high-risk group made up 28% of the population and accounted for 59.8% of the adverse outcomes. Intrapartum characteristics were then evaluated in this high-risk group. Intrapartum evaluation identified the highest risk group with a C/S rate of 40% and adverse outcome rate of 11.3%. CONCLUSION: Incorporation of maternal and antepartum risk factors with FHR analysis can improve the ability to identify the fetus at risk in labor.
INTRODUCTION
Intrapartum fetal heart rate (FHR) monitoring is used in a substantial majority of laboring women in the United States to assess fetal condition. 1, 2 On the basis of the notion that FHR patterns reflect fetal acid-base status and, therefore, fetal oxygenation, FHR analysis is used to infer fetal condition and to determine whether changes in management or expedited delivery are indicated. 3 Unfortunately, the original goal of FHR monitoring, reduction of intrapartum hypoxic-ischemic injury, has not been achieved. Instead, increased rates of surgical delivery and increased cost have accompanied FHR monitoring, with no perceptible effect on neurodevelopmental outcome. 4 Recently, a new classification system for FHR interpretation was proposed by the Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD), with others. 5 The goal of these definitions was to 'allow the predictive value of monitoring to be assessed more meaningfully and to allow evidence-based clinical management of intrapartum fetal compromise.' The NICHD classification system separated FHR patterns into three categories, based solely on characteristics of the FHR.
However, it has been long recognized that maternal and antepartum factors have an important role in fetal-placental development and in newborn outcome. Advanced maternal age, medical disorders such as diabetes and hypertension, and social factors such as tobacco use all increase the potential for placental dysfunction and neonatal compromise. 2 Perhaps because placental function and maternal-fetal oxygen transport are assumed to be a final step in the association between most antepartum factors and fetal-neonatal compromise, monitoring emphasis is on intrapartum FHR patterns without much consideration of other risk factors. This approach fails to consider a patient's a priori risk for placental insufficiency and neonatal hypoxia and acidosis, and assumes that FHR patterns can be interpreted in isolation without consideration of the overall clinical context. This approach may be responsible for the high rate of falsely abnormal findings that are associated with FHR monitoring.
We hypothesized that a model consisting of a combination of antepartum risk factors and intrapartum FHR characteristics would reliably identify those infants at risk for adverse neonatal outcome.
FHR monitoring for X2 h before delivery; available nursing assessment of FHR tracing at least every 20 min; and, available maternal and neonatal outcomes. Patients with known fetal anomalies and those with absent monitoring or outcome data were excluded from analysis.
All study hospitals used an electronic medical record for inpatient maternal and newborn clinical and demographic information, including fetal monitoring in labor. All intrapartum FHR monitor tracings were reviewed in real-time by a labor and delivery nurse at least every 20 min, and the FHR characteristics entered into a bedside computer workstation. For this study, FHR characteristics on all patients were retrieved from the data warehouse, and this information was used to convert the data on FHR characteristics into the appropriate NICHD FHR category.
The maternal historical information, intrapartum and delivery record, and neonatal outcome were also retrieved for analysis. Clinical diagnoses, such as pre-eclampsia and abruption, were made by the managing clinicians. Social risk factors such as tobacco use were self-reported.
Adverse neonatal outcome was defined as admission to the newborn intensive care unit with either a 5-min Apgar score o7 or an umbilical artery pHo7.10. Cases consisted of patients with adverse neonatal outcome. Women in the control group had normal neonatal outcome defined as an umbilical artery pH47.10 at time of delivery or 5-min Apgar score 47.
In order to construct a risk model and then to test it, the study cohort was randomly divided into two subgroups, one for model derivation and one for model validation. Randomization was performed using a Mersenne Twister random number generator. Sixty percent of the study population was assigned to the derivation cohort, and 40% was assigned to the validation cohort.
Two risk models were developed using the derivation cohort. Both risk models correlated maternal and FHR characteristics with newborn outcome. The first model, the initial risk score, was intended to be an initial screening test that would be applicable shortly after presentation to the labor unit. The second risk model, the intrapartum risk score, used variables obtained during labor.
The initial risk score was constructed by analyzing the 31 antepartum and maternal variables (Table 1 ) and FHR characteristics in the electronic record that were available within an hour of initial FHR monitoring. The intrapartum risk score was constructed by analysis of all clinical intrapartum and FHR variables that are entered into the electronic medical record ( Table 2) .
For development of both the initial and intrapartum risk scores, continuously distributed predictor variables were categorized into clinically relevant groupings or, in the absence of clinical guidance regarding categorization, by using quartiles of equal size. Univariable regression was used to determine the independent association of variables with adverse neonatal outcome, and multivariable logistic regression was used to fit a final multivariable risk model. The final model included variables with probability valuesp0.05, odds ratio41.17 or odds ratioo0.85. 6 A weighted scalar score risk value was derived for each predictor variable category by multiplying its regression b-coefficient by 3 and rounding to the nearest integer (referent value ¼ 0). Each patient's risk score was defined as the sum of the risk values based on the individual's data points for each predictor variable. 6 The resulting composite risk score was evaluated in the derivation population to determine its ability to predict adverse neonatal outcome, both as a continuous variable (primary analysis) and in secondary evaluations based on categorizations of risk. Categorization of the risk score variable was performed using quintiles of similar sample size, and post hoc stratification analysis was utilized for more meaningful categories of risk using recursive partitioning.
The risk values for each predictor that was significant in the derivation cohort were then applied to the validation cohort to independently validate the risk score results. The continuous variable risk score (primary risk metric), risk score quintiles (as determined in the derivation population) and the recursive partitioning risk score strata (as determined in the derivation population) were used for analysis.
Receiver operator characteristic (ROC) curves were used to calculate the area under the curve c-statistic for the risk score in both the derivation and validation populations. The c-statistic measures the ability of a predictive variable to correctly classify those with and without a study outcome (for example, cases and controls) as true positives and true negatives, and it ranges from 0.5 (no predictive ability) to 1.0 (exact prediction).
The investigation was approved by the Intermountain Healthcare Institutional Review Board.
RESULTS
During the 29-month study period, there were 62 992 deliveries of singleton newborns at X37.0 weeks. A total of 11 748 patients were excluded, leaving 51 244 patients for analysis. Reasons for exclusion included incomplete information or monitoring duration o2 h (n ¼ 8191) and admission for planned cesarean section (n ¼ 3557). There were 405 (0.77%) patients in the study population with adverse neonatal outcome. The demographics of the study population are detailed in Table 3 . The majority of the patients were white, married and parous. Except for a slightly greater percentage of nulliparous patients in the derivation group, there were no differences between the derivation and validation cohorts.
During construction of the initial risk score, univariable analysis of the 31 antepartum factors and FHR characteristics found 10 to be significantly associated with adverse neonatal outcome ( Table 4) . Each of the significant variables was assigned a weighted value by use of the scalar risk model, the weighting being proportional to the odds ratio for adverse outcome.
These scores were then used to place each patient into a category of low, moderate or high risk ( Table 5 ). The low-risk group included patients with an initial risk score of 0 to 3, and made up 21% of the derivation group; these patients had a risk of adverse neonatal outcome of 0.2%. The moderate-risk group included patients with an initial risk score of 4 to 6, and made up 51% of the total cohort; the incidence of adverse outcome was 0.6%. The high-risk group included women with initial risk scores of 7 to 14, and made up 28% of the total population; this group had an incidence of adverse neonatal outcome of 1.8%.
On initial risk scoring, the high-risk group accounted for 59.8% of all adverse neonatal outcomes. Within this high-risk category, outcomes were further segregated. Patients with an initial risk score of 7 to 8 made up 21% of the total cohort, had a 1.5% incidence of adverse neonatal outcome and accounted for 11.5% of all adverse outcomes. Patients with an initial risk score of 9 to 14 made up 7% of the total cohort, had a 30.0% incidence of adverse outcome and accounted for 76.5% of all adverse outcomes. The intrapartum risk score was then developed, using only the initial score high-risk group (initial score 7 to 15). Intrapartum risk scores were not calculated for those patients in the low and moderate initial risk groups because there were too few cases of adverse neonatal outcome to create a new risk score using intrapartum variables. Using the variables listed in Table 2 , univariate analysis found seven variables to be significantly associated with adverse neonatal outcome ( Table 6 ). Individual patient scores in intrapartum risk scoring ranged from 0 to 16. As with the initial scoring, the intrapartum risk scores were stratified into low-, moderate-and high-risk groups.
The intrapartum low-risk group had a score of 0 or 1, a risk of adverse outcome of 1.0% and a cesarean delivery rate of 13%. The intrapartum moderate-risk group comprised those patients with an intrapartum risk score from 2 to 6; these patients had an adverse neonatal outcome rate of 1.9% and cesarean section rate of 17.8%. The intrapartum high-risk group included patients with an intrapartum risk score of 7 to 14; they had an 11.3% risk of adverse neonatal outcome and a cesarean delivery rate of 40% ( Table 7 ).
The methods above were then applied to the validation cohort. Performance of the initial risk and intrapartum risk models were similar in the two cohorts. For the initial risk score model, the c-statistic for the ROC curve utilizing these data were 0.710 for the derivation population and 0.659 for the validation population. For the intrapartum risk score modeling (on initial high-risk patients) the c-statistic for the ROC curve utilizing these data were 0.752 for the derivation population and 0.691 for the validation population.
DISCUSSION
We have shown that a combination of antepartum risk factors and FHR characteristics seen on initial monitoring can identify the subset of term, laboring patients at greatest risk for adverse neonatal outcome. Once this is done, intrapartum FHR characteristics can further stratify the initial high-risk group, identifying those at highest risk. Initial risk scoring of our cohort identified the 28% of the population that accounted for 60% of the adverse neonatal outcome. Patients in the initial high-risk and intrapartum high-risk group comprised only 0.9% of the entire derivation cohort, but they accounted for 12.3% of all babies with adverse outcome. At the same time, patients with low initial risk scores were identified as being at very low risk for untoward outcome. Our patients with initial risk scores of 3 or less accounted for 420% of the cohort, and had only 0.8% of all adverse neonatal outcomes. Only 0.2% (1 in 434) of these babies was admitted to the newborn intensive care unit with a low Apgar score or umbilical artery pH.
The original intent of electronic fetal monitoring was to identify FHR changes indicating fetal compromise, which would allow intervention that would reduce the incidence of subsequent cerebral palsy. This goal has not been met, likely for a number of reasons. Importantly, adverse outcomes are rare among babies delivered at term, 3 and the proportion of cases thought to be due to intrapartum factors is now estimated to be o20%, 7, 8 not the 50% that was assumed at the time of introduction of electronic FHR monitoring. 9 Given the low prevalence of the outcomes, it should be no surprise that FHR monitoring has performed poorly as a screening test for intrapartum fetal death and cerebral palsy in general obstetric populations. Even when applied to high-risk populations, intrapartum FHR monitoring has unacceptably poor positive and negative predictive values. 10 There is broad agreement that NICHD category I FHR patterns 'are normal and not associated with fetal academia', and that a category III FHR pattern is 'abnormal and conveys an increased risk for fetal academia'. 3 However, category III FHR patterns are very uncommon, occurring in about 1 of 900 term singleton labors in our population. 11 Although a category III FHR pattern may or may not predict newborn compromise reliably, its rarity makes it a poor tool for identifying the fetus at risk of compromise.
Category II FHR patterns are considered 'indeterminate'. 5 This category comprises a very broad range of patterns, including a number of characteristics that might be considered worrisome in some clinical circumstances: bradycardia without decreased variability; absence of FHR accelerations with stimulation; absent variability without late decelerations; recurrent variable decelerations with minimal variability; and, variable decelerations with slow return to baseline. 5 Category II FHR patterns occur in 84% of laboring patients at term, and are present for 39% of the time in the last 2 h before delivery. 11 The wide spectrum of FHR patterns in category II and the commonness of the category make it an unreliable indicator of fetal status.
As oxygenation is thought to be the most important component of fetal well-being, and because cerebral hypoxia has been accepted as the final pathway to newborn neurologic abnormalities caused by intrapartum events, nearly all attention has been focused on assessment of fetal oxygen status. Unfortunately, assessment of FHR patterns and measurement of fetal oxygen saturation by pulse oximetry have not proven to be reliable indicators of condition;
4,12 analysis of fetal ST-segment characteristics is currently under investigation. 13 These approaches ignore all other risk factors and clinical characteristics, focusing solely on the FHR. Other maternal, antepartum and intrapartum risk factors for adverse neonatal outcome have been identified. [14] [15] [16] [17] Although populations and methods have varied between reports, advanced maternal age, prior neonatal death, thick meconium, alcohol use, pre-eclampsia, hypertension and diabetes have been consistently associated with an increased risk of newborn compromise.
Our study has the strengths of a large number of patients for analysis and a robust database, including FHR characteristics. The confirmation of our results in a large validation cohort adds strength to the results. Our study population is low risk, which supports a broad external validity of our study. Also, our risk scoring system lends itself to application in a computerized algorithm that could be adapted easily to most hospital software systems. Weaknesses include the retrospective nature of our data and the relative homogeneity of our population. Most important, we have used newborn intensive care unit admission with either a low umbilical artery pH or low Apgar score as an indicator of newborn compromise; our health system does not require umbilical artery pH testing on all deliveries, and such data are not available for the large majority of patients.
Our system is not a perfect screening and diagnostic algorithm for identifying adverse neonatal outcome. However, incorporation of maternal and antepartum risk factors with FHR analysis can improve the ability to identify the fetus at risk. Prospective evaluation of our system will be needed to confirm its utility. Also, testing in other populations that are demographically different from ours will be needed, as modifications in risk factor inclusion and score weighting may be required. 
